These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6983742)

  • 1. T cell-mediated cytotoxicity against HBsAg-coated Chang cells in patients with chronic hepatitis: evidence for cytotoxicity mediated by delayed hypersensitivity T cell reaction.
    Nonomura A; Ohmori K; Ohta G; Kato Y; Kobayashi K; Nishimura I; Sugioka G
    Tohoku J Exp Med; 1982 Oct; 138(2):139-50. PubMed ID: 6983742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH).
    Barnaba V; Levrero M; Franco A; Ruberti G; Musca A; Bonavita MS; Balsano F
    Liver; 1986 Feb; 6(1):45-52. PubMed ID: 3487021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
    Warnatz H; Rösch W; Gerlich W; Gutmann W
    Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms responsible for in vitro cell-mediated cytotoxicity to autologous hepatocytes in children with autoimmune and HBsAg-positive chronic liver disease.
    Mondelli M; Mieli-Vergani G; Bortolotti F; Cadrobbi P; Portmann B; Alberti A; Realdi G; Eddleston AL; Mowat AP
    J Pediatr; 1985 Jun; 106(6):899-906. PubMed ID: 3998945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.
    Alberti A; Realdi G; Bortolotti F; Rigoli AM
    Gut; 1977 Dec; 18(12):1004-9. PubMed ID: 304824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.
    Mieli-Vergani G; Vergani D; Portmann B; White Y; Murray-Lyon I; Marigold JH; Woolf I; Eddleston AL; Williams R
    Gut; 1982 Dec; 23(12):1029-36. PubMed ID: 6983473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity in acute and chronic hepatitis.
    Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
    J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis.
    Nagafuchi S; Kashiwagi S; Hayashi S; Inoue T; Imayama S; Takeshita M; Kikuchi M
    Clin Exp Immunol; 1985 Sep; 61(3):569-76. PubMed ID: 4075587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to hepatitis B surface antigen in man.
    Hanson RG; Hoofnagle JH; Minuk GY; Purcell RH; Gerin JL
    Clin Exp Immunol; 1984 Aug; 57(2):257-64. PubMed ID: 6235987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of human peripheral blood T-lymphocyte clones activated by hepatitis B virus surface antigen.
    Hakim AA
    Experientia; 1985 Dec; 41(12):1579-84. PubMed ID: 2416588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage.
    Vergani D; Mieli-Vergani G; Mondelli M; Portmann B; Eddleston AL
    Liver; 1987 Dec; 7(6):307-15. PubMed ID: 3437792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocyte subsets implicated in cytotoxicity in autologous hepatocytes in chronic active hepatitis patients with active viral replication.
    Stefanini GF; Mazzetti M; Zunarelli P; Baraldini M; Pignatelli M; Canonica GW; Miglio F; Gasbarrini G
    Clin Immunol Immunopathol; 1986 Aug; 40(2):214-23. PubMed ID: 3487403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphocyte cytotoxicity against HBsAg-coated hepatocytes in patients with chronic hepatitis. II. Effects of treatment of target cells with anti-HBs antibody (author's transl)].
    Nonomura A; Nishimura I; Kurumaya H; Haratake J; Oomori K; Kato Y; Kobayashi K; Sugioka G; Ohta G
    Nihon Shokakibyo Gakkai Zasshi; 1981 Oct; 78(10):1947-52. PubMed ID: 6977062
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
    Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
    J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphocyte cytotoxicity against HBsAG-coated hepatocytes in patients with chronic hepatitis. I. Significance of T-cell medicated cytotoxicity (author's transl)].
    Nonomura A; Nishimura I; Haratake J; Kurumaya H; Oomori K; Kato Y; Kobayashi K; Sugioka G; Ohta G
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1760-71. PubMed ID: 6976465
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune mechanisms for hepatic fibrogenesis. T-lymphocyte-mediated stimulation of fibroblast collagen production in chronic active hepatitis.
    Casini A; Ricci OE; Paoletti F; Surrenti C
    Liver; 1985 Jun; 5(3):134-41. PubMed ID: 3876501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.
    Vyas AK; Sharma BC; Sarin SK; Trehanpati N
    Liver Int; 2018 Jan; 38(1):38-49. PubMed ID: 28500636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.